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Abstract
Primary care providers have reported an increase in the transgender patients seeking care in
outpatient clinics; however, providers lack experience in caring for these individuals. As a result,
the transgender patients are at risk for experiencing significant adverse events, dissatisfaction
with healthcare, and potential death. Transgender population health promotion is necessary to
improve overall quality of life. The transgender patients experience social and health inequities,
and disproportionate obstacles compared to other populations. Provisions to ensure adequate
health services for the transgender patient are necessary. This article focuses on health
promotion aspects of transgender care, and will provide the primary care provider with an
overview of caring for this unique patient population.

Introduction
Health care for transgender patients within the United States has been fragmented. Many have
not received primary care services from their health care providers due to perceived
stigmatization and discrimination related to conflicted gender identity disorders. 1, 2 Transgender
patients have reported difficulty in finding a clinic and provider from whom they feel
comfortable receiving care. 3 In June 2011 a national directive was mandated for use throughout
the nation’s Veterans Administration (VA) systems. 4 To fulfill this mandate there must be
significant change and improvement in the care provided to transgender veterans. The
transgender veteran population has been increasing in numbers within Veterans Administration
Medical Centers (VAMC). Lack of sufficient skilled primary care providers has further
marginalized this population in the health care system. 2 The purpose of this article is to delineate
different vernacular to enhance provider understanding of gender identity and to improve the
comfort and confidence levels of primary care providers who care for this population.
Common Transgender Vernacular
A sex is always assigned to us at birth. This term is often used interchangeably with the term
gender, but technically sex is describing only physical phenotypic typical characteristics.
Conventionally there are two options; male or female and for the rest of our lives this determines
whether we live with masculine or feminine identity.
Gender is the social categories that are differentiated by its psychosocial characteristics
and role expectations. Gender identity based on societal norms is assigned and grounded on sex.
This assignment means a typical gender identity is associated with certain things (e.g. facial
features, make-up) and physical characteristics (broader shoulder, longer limbs). Societal norms
use these understandings for documentation in the electronic health record where the only
available choices are male or female. However, gender is on a spectrum and one’s sense of self
as a gendered person (as man woman both or neither) cannot be labeled from outside, rather it is
individuals who can truly define their gender. Gender identity may or may not match the natal
sex or gender given at birth and may not conform to conventional expectations of maleness or
femaleness. Change in gender identity can occur at any age as it is not permanent or fixed.
It is important to differentiate that conflicted gender identity is not the same as sexual
orientation. Sexual orientation refers to physical and sexual attraction to the same or another
gender. Sexual orientation is not based on gender identity or vice versa as each individual is
unique. Therefore, it is important for healthcare providers to understand that the sexual
orientation questioning is not necessary for a complete health and physical examination;
however, it is important to identify age appropriate risk factors screening and counseling in a
nonjudgmental way.
Transgender and Gender non-conforming
Transgender is an umbrella term for anyone whose gender identity does not match the sex or
gender they were assigned with at birth; individuals often sense this is different at a very young
age. 5 Gender nonconforming means that an individual does not necessarily fall into a category
of male to female or female to male. In other words, it may describe the way someone identifies
when their gender identity does not match the definitions available or the definition society gives
us. Many transgender or not gender conforming individuals feel that they do not fit in either the
male or female category. 6 The following definitions highlight different terms: 7-11

•
•

•
•
•
•

Gender Identity: a person's innate, deeply felt psychological identification as male or
female, which may or may not correspond to the person's body or designated sex at birth.
Gender Expression: all of the external characteristics and behaviors that are socially
defined as either masculine or feminine, such as dress, grooming, mannerisms, speech
patterns and social interactions.
Sexual Preference: an individual's physical and/or emotional attraction to the same and/or
opposite gender. "Heterosexual," "bisexual" and "homosexual" are all sexual orientations.
Gender Identity Disorder (GID): a conflict between one's gender identity and one's
designated natal/birth sex.
Gender Dysphoria: severe distress and discomfort caused by the conflict between one's
gender identity and one's designated sex at birth.
Gender Transition: the process through which a person modifies his or her physical
characteristics and/or manner of gender expression to be consistent with his or her gender
identity.

Patient Presentation
Samantha a 35 year old adult natal female is accompanied by her life partner Alex in clinic
today. She is adopted and does not have any family medical information. Her medical history
consists of several incidents of treated sexually transmitted diseases (STDs) with a history of
multiple past sexual partners. She has not been to a health care provider for 7 years, presenting
today to initiate primary health care. The last time that she was seen by a health care provider
was for diagnosis and treatment for Chlamydia and Gonorrhea. At that time she was educated
about STDs such as hepatitis or HIV. Since that time she denies any unprotected sexual contact.
Samantha’s history includes multiple episodes of attempted suicide, and until last year, she was
an active “cutter”. She verbalizes feeling relief of stress and anger after she cuts herself. She
currently is seeing a psychologist who has diagnosed her with Gender Identity Disorder (GID).
Samantha explains that she knew that she was born with the wrong “parts” pointing at her
genitalia and breasts, and that, “None of this was a problem until about 12 years old and I began
to develop breasts”. She also said that she was forced to run away to survive, and that she was
raped by her neighbor and couldn’t go through that again. She recalls that she later joined the
Marines to escape her life. She tells you that her relationship with Alex has given her the support
and confidence needed to “come out” and transition to male. Past medical history includes
posttraumatic stress disorder.
Physical Examination:
Vital signs within normal limits. The patient is alert, oriented, and pleasant, in no acute physical
distress. Affect is appropriate and she is cooperative with exam, does not appear anxious or
depressed. Complete physical assessment including gynecological and breast exam within
normal limits. Abnormal finding noted for scarring on abdomen, inner arms, in popliteal fossa,
and inner thighs bilaterally. No new wounds.
Laboratory Work-up:
Lipid Profile, CBC, CMP, HgbA1C and TSH P within normal limits. Pap with HPV-DNA
negative. Substance abuse and domestic violence screening are negative.
Diagnoses:

Gender Identity Disorder
Gender Dysphoria
Treatment/Management
Continue Psychological Services. Pap and pelvic exam should be based on current guidelines.
STD screening should be based on risks; Yearly mantoux and full skin exam. Ultrasound any
breast tissue and lymph nodes every other year and lab testing based on guidelines.
Patient Education
Samantha is planning to transition to male. She plans to receive testosterone therapy. Precautions
and contraindications were discussed, which included cardiac health and cancer screenings.
Endocrinology, cardiology or hematology provider must clear her if she develops
hyperlipidemia, elevated BP, kidney failure, prolactinoma, or active thyroid disease.
Testosterone can impact lipids, therefore regular exercise and a balanced diet is important as
overweight patients may have more difficulty achieving amenorrhea and masculinization. Postoophorectomy patients may be at higher risk for osteoporosis, despite being on testosterone if
they were at a very low estrogenic state as it may confer highest risk. Calcium and vitamin D
supplements are recommended. Return yearly for chest wall exam or of any breast tissue and
cervical cancer screening in next 5 years per guideline. Monitor BP every one to three months,
and adult immunization (per CDC guidelines) to be completed with next clinic visits.
Discussion
For testosterone therapy informed consent is necessary. To receive this therapy it should be
patient driven, with the provider facilitating informed consent to do no harm. Menses cessation
should be tailored to the individual. Provider should have an honest discussion about the
unknown effect of testosterone on ovaries and potential. Cardiology consult is appropriate for
unstable heart disease. Considerations include risk stratification for diseases including
hyperlipidemia, diabetes, liver impairment or chronic liver disease, cigarette smoking, active
substance use, renal impairment, stable coronary artery disease, hypertension or congestive heart
failure, valvular disease, extreme obesity, thyroid disorder or a strong family history of breast
cancer, hyperlipidemia or diabetes. If patient has previously been taking thyroxin replacement
for hypothyroidism, it is important to monitor TSH and free T4 closely as testosterone can affect
thyroid binding globulin. Overall hormone therapy can impact the entire endocrine system.
Testosterone can cause erythrocytosis, if elevated make sure testosterone levels are not above
average male physiologic range. If this persists, consider switching to transdermal or slight
decrease in the dosage. Osteoporosis screening female to male post-oophorectomy who are not
on testosterone or on a low dose testosterone are especially at risk for osteoporosis. Female to
male on aromatase inhibitors may also have low estrogen and therefore may be more at risk.
Calcium and vitamin D supplements are recommended. Consider a Dexa scan early as a baseline
and then within five years of gonad removal. 5, 12-14
Follow-up
Education and patient evaluation by trained medical and mental health providers are strongly
recommended before initiating hormones or any surgical procedures. Ongoing physical and
mental health monitoring by providers ordering treatment is also necessary to provide safe,

efficacious care. 12-13Written resources as well as reliable and factual web resources should be
provided to patients.

Transgender Health Care Part 2: Grand Rounds

Patient Presentation/Patient History
The two patients discussed in this article, Chris and Jessy, are fictional patients in these scenarios. Any
similarities with real people, conditions, and health descriptions are purely coincidental.
Chris, an adult natal male is a nineteen year old college student back home for summer break. He is
dressed casually in jeans and a university sweatshirt. His family consists of his mother, age 57 with a
history of obesity, diabetes, hyperlipidemia, cardiovascular atherosclerosis and previous tobacco use for
25 years. His father recently passed away and his medical history is unknown. He has one sibling, a
healthy younger brother. Chris reports feelings of being born in the wrong body. As a youngster he
knew that he was supposed to be female. He has done well in school but never felt connected with
friends. Originally his mother and teachers thought that he had problems concentrating and they
believed that it created barriers for him to create friendships. He had a few good female friends. Female
and male peers called him names such as, “He-she” and “Queer.” Chris has seen a mental health
provider for Gender Identity Disorder (GID) and gender dysphoria. His mental health provider has
recommended initiating hormone therapy. This letter recommends that his new provider, (that’s you
now), should feel safe to prescribe cross sex hormones to him. Chris does meet DSM4 criteria1for the
diagnosis of gender Identity disorder. He seeks care today to begin treatment with hormones to
transition to female. In the past he has felt hopeless and states, “he may cut off his own testicles to
reduce his testosterone levels”. Chris reports that normally he wears feminine clothing; however, today
his attire is masculine as he didn’t want others to stare at him in the clinic.
Physical Examination:
VITAL SIGNS: within normal limits (WNL).
GENERAL: The patient is alert, oriented, and pleasant, in no acute physical distress. Does not seem
anxious or depressed. Appropriate and cooperative with exam.
HEENT: WNL.
NECK: WNL
CHEST: WNL
CARDIOVASCULAR: WNL
ABDOMEN: WNL.
GENITOURINARY: Normal circumcised penis without lesions. His testes are descended bilaterally without
mass.
RECTAL: Normal resting and voluntary sphincter tone. His prostate is flat, firm, non-nodular, and nontender.

NEUROLOGIC: No focal deficits. DTRs are intact.
MUSCULOSKELETAL: Normal bulk and tone. Ambulates without difficulty.
INTEGUMENT: WNL.
Laboratory Work-up
Lipid panel, CBC with platelets, CMP ordered2. All of these lab results were within normal limits.
Diagnoses
Gender Identity Disorder
Gender Dysphoria
Differential Diagnoses DSM4 criteria for GID:
A strong and persistent cross-gender identification (not merely a desire for any perceived cultural
advantages of being the other sex). In adolescents and adults, the disturbance is manifested by
symptoms such as a stated desire to be the other sex, frequent passing as the other sex, desire to live or
be treated as the other sex, or the conviction that he or she has the typical feelings and reactions of the
other sex.
Persistent discomfort with his or her sex or sense of inappropriateness in the gender role of that sex In
adolescents and adults, the disturbance is manifested by symptoms such as preoccupation with getting
rid of primary and secondary sex characteristics (e.g., request for hormones, surgery, or other
procedures to physically alter sexual characteristics to simulate the other sex) or belief that he or she
was born the wrong sex.
The disturbance causes clinically significant distress or impairment in social, occupational, or other
important areas of functioning.
Based on theDSM4 criteria for hormone therapy are as follows:
1. Persistent, well-documented gender dysphoria; +
2. Capacity to make a fully informed decision and to consent for treatment; +
3. An adult of age 18, younger if emancipated; +
4. Medical or mental health concerns must be reasonably well controlled; as to not exacerbate
existing co-morbidities, or induce additional health conditions. +
5. Patient must be willing and agree to informed consent. +
--------------------------------------------------------------------------------------------------------------------+ Denotes meets criteria. 0 Denotes does not meet criteria
These criteria are a compilation of recommendations from multiple authors 2, 3, 4, 5, 6
--------------------------------------------------------------------------------------------------------------------Jessy is an adult natal male who is 24yrs old from Iowa. He is unemployed at this time however reports
that he does have income working independently as a prostitute in drag within his small town. Jessy
does identify as a male and wishes to transition to a female due to the potential for increased amounts
of money he can earn as a real female. His past history includes being in the Marines for 3 years after
high school. For the last 3 years he has supported himself by prostitution. His family resides in
Minnesota; however, he is not in contact with his family as Jessy does not want them to worry about

him. His family consists of his mother, age 67 with a history of obesity, diabetes, hyperlipidemia,
cardiovascular atherosclerosis and previous tobacco use. His father is 65yrs old with a current and past
medical history of schizophrenia and tobacco use. Jessy has no siblings. He denies ever having true
feelings of being born in the wrong body. Jessy has initiated care to request treatment with hormones to
transition into female. He is dressed in female attire and reports wearing feminine clothing most often.
He admits to having a long history of depression and previous suicide attempts. Jessy has previously
been diagnosed with schizophrenia and notes that he “does not need to take medication any longer”.
Admits to hearing voices but he is able to calm the voices down with drinking alcohol. He smokes 1 pack
per day and drinks a pint of whiskey each day.
Physical Examination
VITAL SIGNS: within normal limits (WNL).
GENERAL: The patient is alert, oriented, and pleasant, in no acute physical distress. Does not seem
anxious or depressed. Affect slow; however, cooperative with exam.
HEENT: WNL.
NECK: WNL
CHEST: WNL
CARDIOVASCULAR: WNL
ABDOMEN: WNL.
GENITOURINARY: Normal circumcised penis with condyloma lesions. His testes are descended bilaterally
without masses.
RECTAL: Normal resting and voluntary sphincter tone. His prostate is flat, firm, non-nodular, and nontender. Large clustered condyloma at anal enteroitus.
NEUROLOGIC: No focal deficits; however, slow responses are noted. DTRs are intact.
MUSCULOSKELETAL: Normal bulk and tone; ambulates without difficulty.
INTEGUMENT: Warm and dry without rash or suspicious lesions.
Laboratory Work-up
Lipids, CBC, CMP, TSH and PSA were ordered and results were within normal guidelines.
Diagnoses
Substance abuse: daily alcohol and tobacco use.
Schizophrenia and Depression
High risk sexual behavior
Genital and anal chondyloma
Differential Diagnoses DSM4 criteria for GID:
See above
Based on the DSM4 criteria for hormone therapy are as follows:
1. Persistent, well-documented gender dysphoria; 0
2. Capacity to make a fully informed decision and to consent for treatment; 0

3. An adult of age 18, younger if emancipated; +
4. Medical or mental health concerns must be reasonably well controlled; as to not exacerbate
existing co-morbidities, or induce additional health conditions. 0
5. Patient must be willing and agree to informed consent. +
--------------------------------------------------------------------------------------------------------------------+ Denotes meets criteria. 0 Denotes does not meet criteria
These criteria are a compilation of recommendations from multiple authors 2, 3, 4, 5, 6
--------------------------------------------------------------------------------------------------------------------Treatment/Management
Jessy does not meet DSM4 Criteria for hormone therapy.
See tables 1A & 2A and tables 1B & 2B for further details.
Follow-up
See tables 1A, B & 2A, B.
Resources for Providers

1. The World Professional Association for Transgender Health (WPATH), Standards of
Care 7 (SOC) originally established as the Harry Benjamin International Gender
Dysphoria Association.
2. The National Endocrine Society 2009 Guidelines for Hormone Therapy for
Transgenderism 2
3. Primary Care Protocol for Transgender Health. (2011), Center of Excellence for
Transgender Health 8
Discussion
Question: Are both of these patients appropriate for beginning cross sex hormone treatment?
Answer: No, Jessy is not appropriate for receiving cross sex hormones as doing so can exacerbate
several of his diagnosed health conditions. See guidelines mentioned above.
See tables 1A, B and 2A, B.

TABLE 1A: MASCULINIZING HORMONES
Eﬀect Expected

Onset in months

Expected Maximum in years

Skin changes/acne

1-6

1-2

Hair growth body/ face

3-6

3-5

Male pattern baldness
Muscle mass increases

6-12

2-5

Redistribution of body fat

3-6

2-5

Cessation of menses

2-6

Clitoral enlargement
Vaginal atrophy

3-6

1-2

Voice deepens

3-6

1-2

Libido increases

2-6

n/a

Variable

Tables 1A&B - Information obtained from multiple sources 2, 4, 5, 9
TABLE 1B: FEMINIZING HORMONES
Eﬀect Expected

Onset in months

Expected Maximum in years

Skin softening

3-6

1-2

Loss of muscle mass

3-6

1-5

Body fat redistribution

3-6

variable

Libido and spontaneous erections
decrease

1-3

1-2

Male pattern baldness halts

1-3

1-2

Breast growth

3-6

2-3

Decreased testicular volume &
sperm production decreases

3-6

2-3

Table 2A
Monitoring of MTF patients on hormones

*Evaluate and monitor for appropriate signs of
feminization and for development of adverse
reactions.

Time measurement to monitor

Every 2–3 months in the first year and then
1–2 times per year.

*Measure serum testosterone and estradiol

Every 3 months.

Serum testosterone levels should be <55 ng/dl.

*Serum estradiol should not exceed the peak
physiologic range for young healthy females, with
ideal levels, 200 pg/ml.

Every 3 months

*Estrogen dosages should be adjusted according to
the serum levels of estradiol.
Doses may fluctuate slightly.
*For individuals on spironolactone, serum
electrolytes particularly potassium should be
monitored.
Every 3 months initially in the first year.

*Routine cancer screening recommended in nontranssexual individuals (breasts, colon, prostate).

*Consider BMD testing at baseline if risk factors
for osteoporotic fracture are present.
In individuals at low risk.

Per normal recommended adult screenings.

Risk Factors: previous fracture, family history,
glucocorticoid use or prolonged hypogonadism.

Sooner in those who are not compliant with
hormone therapy.

*Screening for osteoporosis should be conducted at
age 60.
Tables 1A&B - Information obtained from multiple sources 2, 4, 5, 9

Table 2B
Monitoring of FTM patients on hormones
*Evaluate and monitor patient for appropriate signs
of virilization and for development of adverse
reactions.

Time measurement to monitor
Every 2–3 months in the first year and then 1–2
times per year.

Every 2–3 months until levels are in the normal
physiologic male range:
*Measure serum testosterone levels

Patients using testosterone cypionate injections, the
testosterone level should be measured mid-way
between injections.

With transdermal testosterone, the testosterone
serum levels can be:

If the level is >700 ng/dl or <350 ng/dl, adjust dose
accordingly.

At any time after 1 week.

During the first 3–9 months of testosterone
treatment, total testosterone levels may be elevated;
although free testosterone levels are normal due to
high sex hormone binding globulin levels in some
biological women.

Measure estradiol levels

During the first 6 months of testosterone treatment
or until there has been no uterine bleeding for 6
months.

Estradiol levels should be <50 pg/ml

Measure CBC and liver function tests at baseline
and monitor weight, blood pressure, lipids, fasting
blood sugar and hemoglobin A1c if diabetic.

Every 3 months for the first year and then 1–2
times a year.

Monitor Lipid Levels as it is common for
triglycerides to spike upon starting treatment and
for the next 5 years.
At age 60 or sooner if osteoporotic fracture risk is
present. These include: previous fracture, family

Consider BMD testing at baseline if risk factors for
osteoporotic fracture are present.

history or glucocorticoid use or in those who are
not compliant with hormone therapy.

*If cervical tissue is present, pap smears are
recommended.

Per screening recommendations by the American
College of Obstetricians and Gynecologists.
as recommended by the American Cancer Society

*If mastectomy is not performed, then consider
mammograms.
2A&B Information obtained from multiple sources to compile these information tables Information
obtained from multiple sources 2, 4, 5, 9

1.

2.
3.
4.

5.

6.
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